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Cognition in Rodents
Abstract
Cognition is a loosely defined term with divergent meanings in different disciplines and species. In
human psychology, ‘cognition' is often used in reference to concepts such as ‘mind' or ‘higher mental
functions'. However, in more general terms, ‘cognition' is regularly used to refer to all manner of
information organization by the brain: from collection, to processing, to storage and recognition or
recall. Whereas ‘cognition' would seem to permeate all mental functions, including subjective
perception and innate responses, ‘cognitive ability' has a slightly more specific connotation - something
more akin to intelligence or information-processing ability. Thus, ‘cognition' deals with mental process
structure and ‘cognitive abilities' with natural variations impinging upon functioning at the higher end of
that structure. Although the term ‘cognition' sometimes subsumes or substitutes ‘cognitive ability' in the
literature, understanding this methodological distinction allows us to read across the two fields without
the misunderstandings that classical cognitive psychologists have sometimes shown for cognitive ability
research. 
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Chapter 11
Cognition in Rodents
Christopher Janus, Michael J. Galsworthy, David P. Wolfer, and Hans Welzl
Introduction
Cognition is a loosely defined term with divergent meanings
in different disciplines and species. In human psychology,
‘cognition’ is often used in reference to concepts such as
‘mind’ or ‘higher mental functions’. However, in more gen-
eral terms, ‘cognition’ is regularly used to refer to all man-
ner of information organization by the brain: from collection,
to processing, to storage and recognition or recall. Whereas
‘cognition’ would seem to permeate all mental functions,
including subjective perception and innate responses, ‘cogni-
tive ability’ has a slightly more specific connotation – some-
thing more akin to intelligence or information-processing
ability. Thus, ‘cognition’ deals with mental process struc-
ture and ‘cognitive abilities’ with natural variations imping-
ing upon functioning at the higher end of that structure.
Although the term ‘cognition’ sometimes subsumes or sub-
stitutes ‘cognitive ability’ in the literature, understanding this
methodological distinction allows us to read across the two
fields without the misunderstandings that classical cognitive
psychologists have sometimes shown for cognitive ability
research.
All aspects of cognition in rodents can only be stud-
ied indirectly by collecting behavioral data within suitable
experimental environments. In this domain, there is a lesser
distinction between cognitive processes and cognitive abili-
ties as the predominant model centers on the genetic, phar-
macological, or lesion manipulation of rodents. Resultant
changes in learning, memory, or problem-solving paradigms
then indicate the effect of the gene, drug, or locus on informa-
tion processing. There are no introspective reports to monitor
the associated thought contents. Nevertheless, an increas-
ing number of psychologists, neuroscientists, and geneticists
study cognitive processes in animals as a way to increase
C. Janus (B)
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knowledge of neural and genetic mechanisms influencing
cognitive functioning in normal and diseased states.
Cognitive abilities vary in populations of humans as well
as animals. Behavior genetic studies have provided ample
evidence that variability in behaviors reflecting cognition is –
like almost all types of behavior – to a lesser or greater
extent genetically influenced (Plomin, DeFries, McClearn,
& McGuffin, 2001). Knowing the genetic contribution to
behavior is also essential to determine the extent of environ-
mental influences on behavioral variability. However, inves-
tigating a genotype–behavior relationship is difficult since
many genes have an impact on a single type of behavior,
and each gene affects several different types of behavior.
The genotype–environment complexity is yet another reason
why animals such as rodents provide experimental opportu-
nities otherwise unavailable if humans were the only subjects
studied.
Research investigating the genetic contribution to cogni-
tion in rodents has followed three major lines. In the first line
of research, a handful of laboratories have used a quantita-
tive (or ‘psychometric’) approach to look for genetic or neu-
ronal correlates of general cognitive ability in rats and mice.
General cognitive ability in humans, or ‘g’ as it was labeled
by Spearman (1904), represents the core performance in a
battery of cognitive tests. Similarly, the goal of the equiv-
alent animal research is to develop a battery of cognitive
task for rats or mice from which a general cognitive perfor-
mance, or ‘g’ factor, can be extracted. Such a battery will
then help in the search for alleles or brain properties that
predict or are associated with cognitive performance level
across a range of circumstances. The second line of research
focuses on the contribution of specific genes to cognitive
abilities, normally by manipulating genes and recording the
resultant changes in learning and memory tasks. Based on
the results, models are constructed explaining the molecu-
lar and cellular mechanisms crucial for learning and mem-
ory. A third line of research attempts to unravel the basic
functioning of human mental retardation and senile demen-
tia genes via mouse models. Mouse models carrying simi-
lar gene defects, or transgenically overexpressing mutated
Y.-K. Kim (ed.), Handbook of Behavioral Genetics, 159
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160 C. Janus et al.
human genes implicated in a particular disease, are tools
to investigate the etiology and neuropathological changes
responsible for reduced cognitive abilities. The following
sections deal with these three lines of research in detail.
Quantitative Genetic Approaches to ‘General
Cognitive Ability’
In humans, the almost universally accepted model of cogni-
tive abilities is a statistical one. The essence of the model
was first articulated just over 100 years ago when Charles
Spearman noticed that people who did well on one mental
task tended to do better on other mental tasks, even if those
tasks seemed quite different in cognitive demand (Spear-
man, 1904). Expressed differently, Spearman found that all
cognitive tasks tended to correlate positively with each other.
Spearman deduced that this must mean that they all give, in
part, the same basic information. Beyond that, they have their
own specific information. Spearman called this common core
in performance ‘g’, short for ‘general cognitive ability’.
A century of intensive work including intelligence testing
in fields of academia, military, schools, health, and indus-
try has provided overwhelming support for the practical and
explanatory utility of this approach. The current model is
a slightly more complex hierarchy, describing performance
on a cognitive task as being produced by general cogni-
tive ability variance + specific module variance (e.g., ver-
bal fluency) + variance specific to the task (Fig. 11.1). For
a while, there were various academics who gained popular
mileage by refusing the existence of ‘g’ and instead attempt-
ing to split cognitive abilities into many categories, thus
implicitly denouncing the idea that some people could be
‘generally’ more intelligent than others (e.g., Gardner, 1983).
However, the data repeatedly pointed to commonality along-
side different factors, and this commonality is not a philo-
sophical position, but rather a reality of the data and a key
aspect in understanding important general cognitive prob-
lems such as those encountered in mild and severe mental
retardation. It is also the ‘general’ background against which
specific impairments, such as dyslexia or memory impair-
ments, can be more clearly delineated.
Quantitative genetic studies in humans strongly support
a genetic influence on ‘g’ as well as on specific cogni-
tive abilities and specific tasks (Plomin, 2001), thus indicat-
ing that genes influencing cognitive performance measures
could have their effects at any level, from the specific task
parameters right up (or down) to processes fundamental to
all cognition. This last point is particularly pertinent to the
interpretation of ‘lower scores’ on cognitive tasks in ani-
mal research, as will be discussed later. In short, this is why
animal cognitive research, as with human, greatly benefits
from employing batteries of tasks.
Quantitative genetic research of cognitive abilities, or
‘intelligence’, in rodents began in the 1920s, when human
intelligence research was also in its infancy. Edward Tolman
attempted to explore the genetics of cognitive ability differ-
ences by selectively breeding ‘bright’ and ‘dull’ rats. The
work was continued by his student Robert Tryon and they
found that after eight generations of selective breeding for
performance on a T-maze, there was no population overlap
(original figure presented in Plomin & Galsworthy, 2003).
Such data evidenced genetic contributions to cognitive task
Fig. 11.1 A hypothetical description of a possible clustering hierar-
chy is depicted. Performance in different learning and memory tasks
(bottom level) is affected by specific cognitive abilities (middle level),
and all specific cognitive abilities are influenced by a general cognitive
ability (top level). Genes have an effect on performance by modulating
abilities on all three levels (adapted from Plomin et al., 2001)
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11 Cognition in Rodents 161
performance, whether it be via ‘general’ ability or something
altogether different. Although there was some evidence for
‘g’ in rats from other authors exploring correlations between
tasks (e.g., Thorndike, 1935), this literature lay dormant until
very recently.
The exploration of ‘g’ in mice and rats uses a population
of animals with genetic variation (e.g., outbred strains or F2s
of inbred strains) and subjects them to a battery of tasks.
If general cognitive ability considerably influences perfor-
mance in all cognitive tasks, then an individual should main-
tain its rank score within a group over all cognitive tasks.
Note that ‘g’ in mice does not equate with ‘g’ in humans;
merely the data-reduction method is the same. Simply, the
approach asks how the tasks overlap in information, and
if they all have a common overlap, then this is called ‘g’
to denote that there are some general (genetic or environ-
mental) elements that have a general influence on cognitive
performance.
During the last decade a few laboratories have
attempted to establish a battery of tasks measuring ‘g’
in mice (Galsworthy et al., 2005; Galsworthy, Paya-Cano,
Monleo´n, & Plomin, 2002; Locurto, Fortin, & Sulli-
van, 2003; Matzel et al., 2003). These studies used differ-
ent batteries of cognitive tasks with varying types of moti-
vations and stress levels, and all but one of them (Locurto
et al., 2003) found evidence for ‘g’ in mice, with ‘g’ account-
ing for approximately 30–60% of the variance in perfor-
mance. Nevertheless, these studies have also helped demon-
strate that ‘cognitive’ tasks are strongly influenced by non-
cognitive factors that overshadow the influence of ‘g’ in most
individual tasks. Galsworthy et al. (2002) showed a lack
of correlation between the extracted ‘g’ factor and activity
and anxiety measures, thus evidencing that the commonality
across cognitive tasks was probably not due to these motiva-
tional elements. However, there is clearly substantial random
or non-cognitive variance both within and between cognitive
tasks as the correlations for both of these are surprisingly
low (Galsworthy et al., 2005), offering ample opportunity
for non-cognitive factors to influence ‘cognitive tasks’ more
than cognitive processes do. Furthermore, confounding fac-
tors do not necessarily have uniform influence on all tasks.
Higher activity can generate shorter latencies in problem-
solving tasks, but also higher ‘error-zone’ entries if uninhib-
ited. Similarly, stress can motivate – but beyond a certain
level can also impair performance, with freezing and panic
behaviors seen. Therefore, although confounding traits may
persist across tasks, they may show different expressions
within tasks of different environment or motivation.
In a further step, the variability in ‘g’ can be correlated
with allele variability. Defined outbred lines of mice or the
F2 generation of inbred strains can be used in studies look-
ing for a linkage between high or low ‘g’ scores and specific
genetic markers. This theoretically straightforward approach
is somewhat hampered by the large number of genes that
very likely influence ‘g’, but still feasible. Many mice sub-
jected to several tasks would be necessary to detect individ- AQ1
ual gene influences. Such a study would be time consuming
and costly, and genes contributing only modestly to ‘g’ might
not be detectable at all. Correlation with gross physiological
or neural parameters might provide a more productive entry
point to the natural variability.
This leads directly to the very fundamental question of
what might be the neural basis of commonality across cog-
nitive task performance. Research in humans suggests that
variability in brain structure, or changes in brain structure
during development (Shaw, Greenstein, Lerch, Clasen, Len-
root, Gogtay, Evans, Rapoport, & Giedd, 2006), might be
related to ‘g’ (for review, see Toga & Thompson, 2005).
Tentative data for a similar relationship between brain
size and performance in cognitive tasks also exist for rats
(Anderson, 1993). Variability in processes involved in neural
development and plasticity plausible candidates influencing
‘g’. These processes are complex and difficult to access; so AQ2
detecting a relationship between such nebulous entities and
‘g’ will not be an easy task.
Although the quantitative approach to cognition in rodents
has not yet isolated specific genes that quantitatively con-
tribute to the variability in ‘g’, the concept of what ‘g’ is
and how it could be measured with a test battery is highly
relevant for all other studies looking for genetic influences
on cognition. The search for batteries of cognitive tasks that
measure ‘g’ has served to sharply highlight limitations of dif-
ferent learning and memory tests. A low score of genetically
manipulated mice in learning and memory tests could be due
to disturbed cognitive or due to changes in non-cognitive
processes. Continued efforts to improve batteries of cogni-
tive tasks will reveal the extent to which cognitive as well as
non-cognitive processes influence individual tasks; and hope-
fully they will result in an increasingly improved batteries of
tasks that reliably and efficiently measure core elements of
cognition.
Molecular Genetic Approaches to Cognition
Research in Rodents
Whereas quantitative genetic approaches look at the big pic-
ture of how much genes are influencing different tasks and
the natural structures of genetic influence, most molecular
genetic approaches have a very narrow focus, namely the
contribution of a single gene. Thus, molecular genetic studies
investigate whether a specific gene of interest is essential for,
or modifies, learning and memory in mice, and this is usually
traced through associated brain mechanisms. This bottom-
up approach starts by manipulating specific genes and then
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compares the behavior of genetically engineered mice with
that of their wild-type littermates in learning and memory
tasks. Through gene targeting and transgenesis, genes can
be disabled, reduced, or increased in expression (for review,
see Mu¨ller, 1999). Whereas the so-called constitutive mutant
mice carry the mutation in all cells and throughout their life,
‘conditionally’ mutant mice carry the mutation only in a part
of the brain and/or only during a restricted time in develop-
ment. Furthermore, mutated forms of a gene can replace the
native form so that the gene product loses or changes some
of its properties.
This line of research is less concerned with whether vari-
ability in alleles correlates with variability in cognitive task
performance. As Plomin & Kosslyn (2001) remarked, ‘. . .
although knocking out a gene can have major effects, such
experiments do not imply that the gene has anything to do
with the variation responsible for hereditary transmission of
individual differences within a species’. However, research
with mutant mice has significantly helped to dissect the intri-
cate interrelationship between molecules involved in synap-
tic plasticity, the cellular basis of learning and memory.
Genetically engineering mice is only one way to inves-AQ3
tigate molecular mechanisms of synaptic plasticity. For sev-
eral decades, synapse structure and function have been the
subject of countless in vitro and in vivo studies using dif-
ferent neuroanatomical, neurochemical, neuropharmacolog-
ical, and neurophysiological methods. Thanks to the high
conservation of synaptic plasticity mechanisms, inverte-
brate research has also provided important clues to which
molecules might be critically involved (for review, see, e.g.,
Waddell & Quinn, 2001; Kandel, 2001; Crow, 2004). Thus,
in most cases, one should be able to predict whether a manip-
ulated mouse gene affects learning and memory. Disabling
practically any of the hundreds of molecules involved in
the modification of synaptic transmission could potentially
impair learning and memory. It is, therefore, surprising how
often inactivation of a specific gene does not abolish or even
attenuate learning and memory. This suggests that the pro-
cesses of synaptic plasticity have some potential to compen-
sate for a loss of its parts.
When a mutation-induced deficit in synaptic plasticity is
suspected, mice are usually subjected to learning and mem-
ory tests to prove that there is a real cognitive effect of the
gene. Initially the task of choice was the water maze; later
studies included fear conditioning, object recognition, and
other learning and memory tasks. However, the interpretation
of learning and memory deficits in genetically engineered
mice is limited in studies which employ only one or a few
tasks. Performance in learning and memory tasks cannot be
uncritically equated with cognition, and alternative explana-
tions suggesting non-cognitive deficits as the cause of learn-
ing and memory deficits cannot be ruled out. Including more
cognitive as well as non-cognitive tasks to the test battery
improves the validity of results. To date, the selection of
tasks, task design, and procedures are still highly variable
from laboratory to laboratory.
The multitude of genes whose genetic manipulation
affects learning and memory mirrors the complexity of
synaptic processes. Genes having an impact on learning and
memory processes span a wide range. They may code for
proteins involved in exocytosis, hormones, receptors, protein
members of signaling cascades, proteins involved in tran-
scription and translation, and membrane-bound proteins such
as cell adhesion molecules or postsynaptic density proteins
(for review, see Bolivar, Cook, & Flaherty, 2000; Chen &
Tonegawa, 1997; Morley & Montgomery, 2001). Below we
present a small selection of studies (with a more detailed
review of glutamate receptor mutants) that have found learn-
ing and memory deficits in genetically engineered mice.
The first two articles describing a learning and memory
deficit in mice after inactivation of a gene appeared in 1992.
Mice lacking the expression of the fyn-type tyrosine kinase
were impaired in the water maze (Grant et al., 1992); and
mice defective in αCaMKII had similar problems in spa-
tial navigation (Silva, Paylor, Wehner, & Tonegawa, 1992).
These studies subjected mice to variations of only one learn-
ing and memory task which limited the validity of behav-
ioral results. However, subsequent studies with mutant mice
confirmed the crucial role of kinases such as the αCaMKII
for learning and memory (for review, see Deutsch, 1993;
Elgersma, Sweatt, & Giese, 2004; Shors & Matzel, 1997).
The last two decades have greatly improved our knowl-
edge of presynaptic proteins involved in neurotransmitter
release. To study release mechanisms, mice carrying homo-
or heterozygous mutations in genes coding for release-
related proteins were created, and a few mutant lines
underwent learning and memory tasks. Although almost
exclusively spatial learning in the water maze and fear con-
ditioning were used as learning and memory paradigms,
results indicate that αCaMKII, ataxin I, complexin II, GAP-
43, PAC1, synapsin I and II, Rab3A, RIM1α, and synap-
totagmin mutations impaired performance (for review, see
Powell, 2006).
Hormone receptors whose manipulation affected spatial
learning and memory include receptors for mineralcorticoids
(Berger et al., 2006) and for glucocorticoids (e.g., Oitzl, de
Kloet, Joels, Schmid, & Cole, 1997; Rousse et al., 1997;
Steckler, Weis, Sauvage, Mederer, & Holsboer, 1999). With
glucocorticoid receptors, a point mutation that prevents DNA
binding has been associated with impaired spatial memory
(Oitzl, Reichardt, Joels, & de Kloet, 2000). Genetic manipu-
lations of growth hormones and their receptors have some of
the strongest impacts on cognitive abilities out of the studies
to date. Deletion of TrkB receptors restricted to the forebrain
and occurring only during postnatal development was shown
to impair spatial learning in the water maze (Minichiello
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et al., 1999). However, deficits were especially prominent
in stressful tasks, indicating that the key deficit might not
be purely cognitive in nature. Impaired spatial learning in
the water maze was also seen with mutant mice carrying a
heterozygous deletion of BDNF (Linnarsson, Bjorklund, &
Ernfors, 1997) and GDNF (Gerlai et al., 2001). Heterozygous
BDNF mice had increased striatal dopamine concentrations
and their behavioral responses involving the nigrostriatal
dopaminergic system were altered (Dluzen et al., 2001).
Thus, deletion of a gene might disturb the complex make-up
of biological processes controlling behavior in a way that is
not always predictable. The role of the dopaminergic system
and BDNF in cognition has recently been reviewed (Savitz,
Solms, & Ramesar, 2006).
Two decades ago, Morris, Anderson, Lynch, &
Baudry (1986) demonstrated the importance of NMDA
receptors in spatial learning using a pharmacological tool
to selectively inactivate the receptors. Using a variety
of neuropharmacological tools and cognitive tasks, the
importance of NMDA receptors for many forms of learning
and memory appears well established (for review, see
Nakazawa, McHugh, Wilson, & Tonegawa, 2004; Robbins &
Murphy, 2006). Thus, it is not surprising that knocking out
genes coding for one of the five subunits of the ionotropic
NMDA receptor in the forebrain caused deficits in different
forms of learning and memory. Deletion of the NR1 subunit
in the CA1 region of the hippocampus impaired spatial
learning (Tsien, Huerta, & Tonegawa, 1996) novel object
recognition, context but not cued fear conditioning, and
social transmission of food preference (Rampon et al., 2000).
Deletions can be brought under the control of a food additive.
In such mice, deletions of the NR1 subunit in the CA1 region
during training as well as following training impaired spatial
memory and context fear conditioning (Shimizu, Tang,
Rampon, & Tsien, 2000); and when the NR1 subunit was
deleted in the forebrain, also cued fear conditioning and
taste aversion were impaired (Cui, Lindl, Mei, Zhang, &
Tsien, 2005; Cui et al., 2004). When the NR1 subunit
was switched off for a longer time between training and
retrieval, spatial memory, fear memory, and taste memory
were disrupted, suggesting a role for the NMDA receptor in
maintenance of the memory trace (Cui et al., 2005, 2004;
Shimizu et al., 2000; however, see also the critical comments
on these puzzling results by Day & Morris, 2001).
Another study using mice in which the NR1 subunit was
selectively deleted in part of the hippocampus suggests a
role of the hippocampus in complex but not simple forms
of learning and memory. These mice had no problem with
discriminating two different odors. However, they failed to
use the relationship between odor stimuli as cues (Rondi-
Reig et al., 2001). NR1 heterozygous mice and wild types
acquired context fear conditioning equally well (Frankland,
Cestari, Filipkowski, McDonald, & Silva, 1998; Huerta, Sun,
Wilson, & Tonegawa, 2000). However, they performed worse
than wild types in trace fear conditioning (conditioned and
unconditioned stimulus separated by a time interval; Huerta
et al., 2000) or when a context discrimination was required
(Frankland et al., 1998). The impairments described in the
latter study were partly reversed by environmental enrich-
ment. Finally, already a single point mutations in the glycine
binding site of the NR1 subunit moderately impaired spatial
learning during the first few sessions (Kew et al., 2000).
Manipulating NR2 subunits also affected learning and
memory. Targeted disruption of the NR2A subunit impaired
spatial learning (Sakimura et al., 1995), latent learning in
a water finding task (Miyamoto et al., 2001), auditory fear
conditioning (Moriya et al., 2000), and eye blink condition-
ing (Kishimoto et al., 1997; Kishimoto, Kawahara, Mori,
Mishina, & Kirino, 2001a; Kishimoto, Kawahara, Suzuki,
Mori, Mishina, & Kirino, 2001b). NR2C-deficient mice
showed no deficit in auditory fear conditioning (Moriya
et al., 2000). Mice with targeted deletion of the intracellular
domain of all NR2 subunits failed to acquire a step-down
avoidance response; but they had also motor disturbances
and probably other unmeasured behavioral defects (Sprengel
et al., 1998). Furthermore, the constitutively expressed muta-
tion makes it difficult to separate acute from developmental
disturbances.
Findings of improved performance in NMDA receptor
mutant mice (Tang et al., 1999) were widely publicized
and discussed. Mice whose NR2B subunits were overex-
pressed performed slightly better in a spatial task, contextual
and cued fear conditioning acquisition and extinction, and
novel object recognition. Keeping mice of both genotypes in
an enriched environment improved learning and memory in
wild types but had no further effect on learning and memory
in mutants (Tang, Wang, Feng, Kyin, & Tsien, 2001). These
data suggest a more complex and indirect effect of the muta-
tion on performance enhancement.
Besides the NMDA receptor, other ionotropic and
metabotropic glutamate receptors play a role in learn-
ing and memory (Malinow & Malenka, 2002; Riedel,
Platt, & Micheau, 2003). Mice lacking the AMPA receptor
GluR1 (GluRA) subunit were unimpaired in spatial learning
(Zamanillo et al., 1999). Only a more detailed analysis of
spatial learning using various paradigms revealed selective
working memory deficits (Reisel et al., 2002; Schmitt, Dea-
con, Seeburg, Rawlins, & Bannerman, 2003). Mice lacking
the metabotropic glutamate receptor mGluR1 were slightly
impaired in spatial learning, eye blink conditioning, and
context fear conditioning (Aiba et al., 1994a,b; Conquet
et al., 1994). Part if not all of the deficits might have been due
to the simultaneously observed severe motor disturbances.
Mice with deleted mGluR5 receptors were impaired in a
spatial task and context fear conditioning (Lu et al., 1997),
and mice with deletions of the gene for mGluR7 receptors
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164 C. Janus et al.
committed more working memory errors in the radial maze
and did not learn a conditioned taste aversion (Ho¨lscher
et al., 2004; Masugi et al., 1999). In the latter mice, avoidance
learning was intact (Cryan et al., 2003).
Non-glutamate receptor genes whose manipulation
affected learning and memory tasks include the GABAer-
gic receptors (Crestani et al., 2002, 1999), nicotinic and
muscarinic cholinergic receptors (for review, see Drago,
McColl, Horne, Finkelstein, & Ross, 2003; Matsui, Yamada,
Oki, Manabe, Taketo, & Ehlert, 2004), adrenergic recep-
tors (e.g., Kobayashi & Kobayashi, 2001; Spreng, Cotec-
chia, & Schenk, 2001), and 5HT1B serotonergic receptors
(for review, see Buhot, Wolff, Benhassine, Costet, Hen, &
Segu, 2003). Whether or not deletion of a receptor gene
impaired learning and memory depended on the subunit or
receptor type deleted, the type of task, and the task proto-
col with deficits showing up more readily when cognitive
demands were high.
Learning and memory is based on plasticity in synap-
tic transmission which involves pre- and/or postsynaptic
enzymes and signaling cascades (for review, see, e.g.,
Sweatt, 2004; Thomas & Huganir, 2004; Waltereit &
Weller, 2003). For long-term memory formation, signaling
cascades activate transcription factors which then initiate
protein synthesis (for review, see Davis & Squire, 1984;
Stork & Welzl, 1999). Thus, it is not surprising that dele-
tion of genes that code for links in the Ras-MAP kinase
signaling cascade differentially affected learning and mem-
ory. However, results from different laboratories were not
always consistent. Mice lacking Ras-GRF1 in one labora-
tory were impaired in spatial learning (Giese et al., 2001),
whereas those from another laboratory were not (Brambilla
et al., 1997). The two different lines of Ras-GRF1 mutant
mice differed also in other tasks. Such inconsistencies might
depend on the presence of partially active truncated proteins,
differences in genetic background, differences in task proce-
dures, and/or differences in neo gene insertions (for discus-
sion, see Giese et al., 2001). Similarly, two different lines
of mice lacking the ERK1 isoform of MAP kinase either
performed well (Selcher, Nekrasova, Paylor, Landreth, &
Sweatt, 2001) or were impaired (Mazzucchelli et al., 2002)
in a passive avoidance task. Similar arguments to the above
could explain the discrepancy.
Interfering with the transcription factor CREB in
Drosophila and Aplysia impaired their long-term memory
formation in different learning tasks (for review, see Kan-
del, 2001; Waddell & Quinn, 2001). In rodents, evidence for
a role for CREB in long-term memory came from a num-
ber of sources, including from experiments with mutant mice
(for review, see Carlezon, Duman, & Nestler, 2005; Lonze &
Ginty, 2002). As in experiments investigating the role of the
Ras-MAP kinase signaling cascade in learning and memory,
CREB mutant mice displayed selective long-term memory
deficits. However, results from different laboratories did not
always agree to what extent and in what ways CREB facili-
tates long-term memory in intact animals or when an inacti-
vation of CREB impairs learning and memory.
CREB comes in several different isoforms, and the type(s)
of isoforms deleted might influence results. Mice with a
targeted mutation in the two main isoforms (α and δ) of
CREB showed intact short-term but defunct long-term mem-
ory for contextual fear conditioning and spatial learning
(Bourtchuladze et al., 1994). Forebrain-specific and induced
dominant negative repression of all CREB isoforms also
impaired spatial learning and object recognition but not con-
text fear conditioning (Pittenger et al., 2002). Other studies
did not find deficits in contextual fear conditioning or spa-
tial learning in conditional CREB-deficient mice (Balschun
et al., 2003; Rammes et al., 2000). Gene dosage, back-
ground genetics, procedural differences in behavioral tasks,
and/or differences in neo gene insertions might influence
the extent of memory deficits in mutant mice with disabled
CREB function (Balschun et al., 2003; Gass et al., 1998;
Kogan et al., 1996). Furthermore, non-cognitive performance
abnormalities such as thigmotaxis in the water maze could
contribute to the learning and memory deficits observed in
CR B mutants (Balschun et al., 2003).
Sensory stimulation or electrical stimulation of specific
brain sites alters synaptic strength accompanied by changes
in spine density and spine motility. It has been suggested
that similar changes on a smaller scale might take place
during long-term memory formation (for review, see Bailey
& Kandel, 1993; Nimchinsky, Sabatini, & Svoboda, 2002).
Evidence for this suggestion is sparse. However, indirect
evidence for an involvement of spine motility in long-
term memory formation comes from studies interfering with
synthesis and function of proteins involved in cytoskeletal
dynamics such as actin-regulating proteins or cell adhesion
molecules. Mice lacking beta-adducin, a protein that pro-
motes the binding of the two cytoskeletal proteins actin and
spectrin, are impaired in fear conditioning as well as in a spa-
tial learning task (Rabenstein et al., 2005). Mice with inacti-
vated N-CAM gene, a neural cell adhesion molecule involved
in maintaining synapse structure, were impaired in spatial
learning (Cremer et al., 1994; Stork et al., 2000), contextual
fear conditioning, and to a lesser extent cued fear condition-
ing (Stork et al., 2000) when compared to their wild-type
littermates.
In summary, the use of genetically engineered mice con-
firmed previous results and has expanded our knowledge of
various mechanisms of synaptic plasticity which underlie all
forms of learning and memory. Several aspects of this line
of research should be emphasized. (1) Mutant mice sub-
jected to a battery of tasks have repeatedly revealed unex-
pected pleiotropic effects of genes. Specifically, manipulat-
ing a ‘cognitive’ gene also may change anxiety, locomo-
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tor activity, aggression, or other behavioral or physiological
properties alongside (or instead of) the learning and memory
change. Such effects appeared even when gene manipulation
was restricted to certain brain areas and in time. (2) Related
to the first aspect, manipulating genes may up- or downregu-
late expression of other genes, and it may lead to a readjust-
ment in various systems not directly targeted by the genetic
manipulation. To give just two examples, deleting the CREB
gene in mice upregulated a novel CREB mRNA isoform that
has not been described before (Blendy et al., 1996); and
in mice lacking the α4 nicotinic receptor subunit dopamine
transporter function was impaired (Parish et al., 2005). (3)
Genetic background may exacerbate or compensate for a
deleted gene. Even when careful breeding schedules are
employed and mutant and wild-type littermates are used
for testing, a mutation-induced defect may show up with
one genetic background but not with another. Mouse strains
greatly differ in cognitive (see, e.g., Brooks, Pask, Jones, &
Dunnett, 2005) as well as in non-cognitive behaviors (see,
e.g., Kim, Chae, Lee, Yang, & Shin, 2005). (4) Lines of mice
with the same gene targeted but created in different labora-
tories sometimes differ in their behavioral phenotype (see,
e.g., Brambilla et al., 1997 versus Giese et al., 2001). Par-
tially active truncated proteins and/or differences in neo gene
insertions might be responsible for such discrepancies. (5)
Performance in learning and memory tasks cannot be uncrit-
ically equated with cognition. As quantitative genetic stud-
ies convincingly demonstrated each individual task depends
on non-cognitive factors, on specific cognitive abilities, and
on general cognitive ability. Testing mutant mice in just one
or two cognitive tasks tells us little about the manipulated
gene’s impact on cognition. For a valid conclusion mice have
to undergo a battery that includes several cognitive as well as
non-cognitive tasks. Only with a full behavioral profile can
the gene effect be sensibly characterized.
Modeling Human Cognitive Disabilities
in Mice
Human cognitive impairments with known or suspected
genetic causes or genetic risk factors occur mainly dur-
ing early development as mental retardation or later in life
as senile dementias. When the genes causing or promoting
dementia are known, an attempt can be made to model the
disease in mice by introducing similar mutations, or selecting
mutations that replicate part of the pathology. The goal of this
line of research is to understand disease etiology at the most
fundamental biochemical levels and, with the help of the
model, to develop therapeutic strategies. The approach could
be called a top-down–bottom-up approach because first the
genetic locus has to be detected in affected humans before
the genetic defect can be modeled in mice employing similar
techniques as described in the previous section.
Mental Retardation
Clinical research has identified several dozens of sin-
gle genes or chromosomal regions whose mutation
causes mental retardation (for review, see Inlow & Res-
tifo, 2004; Weeber, Levenson, & Sweatt, 2002; see
also Online Mendelian Inheritance in Man (OMIM)
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi). Most forms
of mental retardation are syndromic, i.e., besides cognitive
deficits the clinical picture includes other anatomical, physi-
ological, and behavioral symptoms. Genetic background and
environmental influences modulate cognitive deficits as well
as other symptoms to a larger or smaller degree. These
characteristics of mental retardation caused by single gene
mutation, i.e., pleiotropic effects of genes and dependence
of the phenotype on the genetic background, resemble the
observations made in other mutant mice as described in the
previous section.
To model mental retardation, the homologues of human
genes known to cause mental retardation were deleted or
replaced by mutated forms in mice (for review, see, e.g.,
Branchi, Bichler, Berger-Sweeney, & Ricceri, 2003; Welzl,
D’Adamo, Wolfer, & Lipp, 2006). The best investigated
mouse model is that for fragile X syndrome, the most com-
mon form of hereditary mental retardation (for review, see
Bakker & Oostra, 2003; Kooy, 2003). Fragile X syndrome
in humans is due to a massive triple repeat expansion in the
Fmr1 gene on the X chromosome causing hypermethylation AQ4
and silencing that gene (Jin & Warren, 2003). Besides mental
retardation, the syndrome includes anatomical features such
as elongated faces and large testicles alongside behavioral
changes such as hyperkinesia. When a homologous triple
repeat expansion was introduced into mice, however, only
moderate instability was observed (Bontekoe et al., 2001).
Mice with deleted Fmr1 gene displayed some but not all
anatomical features (for review, see Bakker & Oostra, 2003;
Kooy, 2003). In more than 90% of adult mutant mice, testes
were enlarged but facial features were normal. Dendritic
spines of mutant mice showed anomalies similar to those in
human patients, and mutants were only slightly impaired in
learning and memory tasks. The mild behavioral phenotype
seemed to be dependent on the genetic background.
Mouse models for other forms of hereditary mental retar-
dation yielded similar results, i.e., symptoms were usually
weaker than in human patients or even completely absent in
the mouse model. Relatively mild impairments in learning
and memory tasks accompanied models for Coffin–Lowry
syndrome (Poirier et al., 2006), GDI 1 mental retarda-
UN
CO
RR
EC
TE
D 
PR
OO
FS
Book Yong-Kyu, Kim 9780387767260 Proof1 November 26, 2008
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
166 C. Janus et al.
tion (D’Adamo et al., 2002), Rett syndrome (Shahbazian
et al., 2002), Agtr2 mutation with X-linked mental retar-
dation (Sakagawa et al., 2000), L1 mutation and CRASH
syndrome (Fransen et al., 1998; Law et al., 2003; Wolfer,
Mohajeri, Lipp, & Schachner, 1998), and neurofibromatosis
type 1 (for review, see Costa & Silva, 2003). Most of these
‘mental retardation’ genes belonged to the class of genes
listed in the previous section, i.e., genes coding for proteins
involved in synaptic plasticity.
Critical interpretation problems similar to those listed at
the end of the previous section apply also for the present sec-
tion (pleiotropic effects, mutation-induced changes in non-
targeted systems, genetic background effects, differences
between lines targeting the same gene, need for improved
cognitive test batteries). In addition, syndromes of mouse
models only partly replicate the clinical picture. One possi-
ble explanation for that observation could be a better com-
pensatory mechanism for deleted genes in mice. Another
explanation might be the lack of good tasks to measure ‘g’
in mice compared to the available tasks measuring ‘g’ in
humans. Most of the tasks tapping into cognition in mice are
probably too simple and can be mastered even after a reduc-
tion in cognitive abilities. Furthermore, cognition in humans
is highly dependable on language. It is possible that lan-
guage in humans is more sensitive to disruption than learning
and memory tasks such as spatial learning or conditioning in
mice.
Senile Dementia of the Alzheimer Type
Aging, in conjunction with genetic, epigenetic, and environ-
mental factors, can compromise brain function, eventually
leading to brain degeneration. Although the decline is typ-
ically a gentle one, the general consensus is that no form
of memory is completely spared during aging (Fratiglioni,
Small, Winblad, & Ba¨ckman, 2001). Dementias are charac-
terized by progressive and accelerated decline in cognitive
function that results from loss of the underlying neuronal
architecture. Patients suffering from advanced Alzheimer’s
disease (AD), fronto-temporal dementia and Parkinsonism
linked to chromosome 17, vascular dementia, corticobasal
degeneration, or Pick’s disease show cognitive impairment
that is indicative of widespread neuronal damage. Yet each
disease possesses a unique cognitive phenotype that emerges
from a patterned destruction of specific neuronal architecton-
ics (for review, see Lee, Goedert, & Trojanowski, 2001).
AD is the most prominent of the dementias and based on
cognitive tests accounts for more than 75% of patients suffer-
ing from dementia (Price, Davies, Morris, & White, 1991).
The major clinical symptom of AD is a progressive
decline in cognitive performance with compromised learn-
ing, memory, and speed of problem solving (Albert, 1996),
sometimes accompanied by delusions, depression, agita-
tion, and aggressive behavior (Victoroff, Zarow, Mack,
Hsu, & Chui, 1996). Although cognitive evaluation is indica-
tive of AD, a definitive diagnosis is only reached post-
mortem based on neuropathological changes consisting of
senile plaques, predominantly containing amyloid-β (Aβ)
protein and neurofibrillary tangles, composed of tau pro-
tein (Fig. 11.2; Price et al., 1991). These changes are
accompanied by neuronal damage and death mainly in
brain regions critical for learning and memory such as
the neocortex, hippocampus, amygdala, anterior thalamus,
and basal forebrain (Arnold, Hyman, Flory, Damasio, &
Van Hoesen, 1991; Horn et al., 1996; Hyman, Van Hoe-
sen, Damasio, & Barnes, 1984; Morrison & Hof, 1997;
Samuel, Terry, Deteresa, Butters, & Masliah, 1994; White-
house et al., 1982). In addition, the functionality of the
monoaminergic and cholinergic systems is reduced (Braak &
Braak, 1994; Jope, Song, & Powers, 1997; Mattson & Ped-
ersen, 1998; Tong & Hamel, 1999). Early onset AD cases
are mostly familial and linked to the presence of autosomal
dominant mutations. Mutations causing familial AD affect
at least one of three different genes that encode the amyloid
precursor protein (APP) or the presenilins (PS1 or PS2). Fur-
thermore, the ApoE4 allele of apoliprotein (apoE) gene is
known to be a potent susceptibility factor for late-onset idio-
pathic (‘sporadic’) form of AD (reviewed in Selkoe, 1997).
The identification of gene mutations associated with AD
and other tauopathies allowed the creation of mice carry-
Fig. 11.2 Comparison of plaques and tangles in human AD patients
(above) and transgenic mouse models (below). (A) Senile plaques in
cortex of a human AD case, stained for pan Ab species. (B) Senile
plaques in cortex of Tg2576 mice, stained for pan Ab species. (C)
Tangles in the cortex of human patient, stained with MC1 antibody
(detects paired helical filaments). (D) Tangles in the cortex of Tgr4510
mice, stained with MC1 antibody [picture supplied by one of the authors
(Christopher Janus)]
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ing either mutated or wild-type forms of human AD-causing
genes. These transgenic mice should replicate the relevant
features of these diseases, including neuropathology and
associated cognitive deficits. In light of what is known
about AD in humans, a mouse model should (1) replicate
at least one and preferably more pathologic hallmarks of
AD; (2) should exhibit cognitive deficits in different behav-
ioral paradigms targeting the same memory system; (3) in
models employing genetic mutation(s), phenotypic changes
described in 1 and 2 should be associated with the pres-
ence of a mutation(s) (these phenotyping effects should be
absent or less pronounced in age-matched mice expressing
wild-type (wt) gene alleles expressed at equal (or greater)
steady-state levels as the mutated allele(s)). Although trans-
genic mice might never recapitulate all facets of the human
disease, transgenic mouse models for AD present unique and
important systems for in vivo study of the pathophysiology
of a gene of interest.
Most of the mouse models which replicate amyloid
pathology express high levels of APP and its metabolite Aβ
peptide, with temporal and spatial expression pattern of the
transgene depending on the promoter used. Commonly used
promoters include the APP promoter (Lamb et al., 1993), the
brain-enriched Prion protein promoter (Chishti et al., 2001;
Hsiao et al., 1995, 1996), the platelet-derived growth factor
b-chain (PDGFb) promoter (Games et al., 1995) (both PrP
and PDGF promoters resulting in a transgene expression also
outside of the CNS), or the neuronal-specific Thy-1 promoter
(Sturchler-Pierrat et al., 1997).
Learning and memory in mouse models of AD. Inter-
AQ5
estingly, mice overexpressing human PS1 wild-type and
mutated genes developed no overt amyloid plaque pathol-
ogy (Citron et al., 1997; Duff et al., 1996). Intensive behav-
ioral characterization of these mouse lines revealed no sen-
sorimotor or spatial reference memory deficits (Holcomb
et al., 1999, 1998; Janus et al., 2000a). The transgenic models
which most convincingly replicated AD-related neuropathol-
ogy overexpressed human mutated APP (Indiana mutation:
Games et al., 1995; Swedish mutation: Andra et al., 1996;
Hsiao et al., 1996; Swedish and Indiana mutations: Chishti
et al., 2001; Li et al., 2004; Janus et al., 2000b; J20 mice:
Mucke et al., 2000; London mutation: Moechars et al., 1999;
APP and PS1 genes: Borchelt et al., 1996; Dineley, Xia,
Bui, Sweatt, & Zheng, 2002). A detailed description of
all transgenic lines is presented in reviews which chroni-
cle the complete history of APP transgenesis and the char-
acteristic of specific lines (Ashe, 2001; Dodart, Mathis,
Bales, & Paul, 2002b; Greenberg et al., 1996; Higgins &
Jacobsen, 2003; Janus, Phinney, Chishti, & Westaway, 2001;
Janus & Westaway, 2001; Seabrook & Rosahl, 1999; van
Leuven, 2000). Most of the transgenic APP mice rapidly
increased Aβ levels and amyloid plaque deposition with
age. These mice also recapitulated other neurological fea-
tures of AD (astrogliosis, microgliosis, cytokinine produc-
tion, oxidative stress, dystrophic neurites) but no overt neu-
ronal loss. Behavioral studies from different laboratories
found that these mice were significantly impaired in spatial
reference memory in the water maze, in working memory
evaluated in a radial arm water maze, in the T-maze test, Y-
maze, object recognition test, and contextual and trace fear
conditioning. AQ6
Another main pathological feature of AD, apart from Aβ
plaques, is the formation of neurofibrillary tangles. Inter-
estingly, no detectable neurofibrillary tangles developed in
transgenic mice overexpressing APP and/or PS1 on different
genetic backgrounds. A recently introduced triple transgenic
mouse model addressed the relationship between amyloid
and tau pathology. The triple transgenic AD mice consist of
APP (Swedish), PS1, and tau mutations (Oddo, Caccamo,
Kitazawa, Tseng, & LaFerla, 2003a). These mice develop
Aβ plaques in an age-dependent fashion, first in the neocor-
tex and then later in the hippocampus. The development of
neurofibrillary tangles followed Aβ pathology. Tangles first
appear in the hippocampus and later spread to the cortex
(Oddo et al., 2003b). The triple transgenic AD mice also
develop an age-dependent synaptic dysfunction which pre-
ceded plaque and tangle formation (Oddo et al., 2003b),
and an age-progressing memory impairment that correlated
with the accumulation of intraneuronal Aβ (Billings, Oddo,
Green, McGaugh, & LaFerla, 2005). The regional and tem-
poral pattern of pathology development observed in triple AQ7
transgenic AD mice is reminiscent of the development of
human AD pathology. Also, the appearance of Aβ pathology
before tau pathology supports the amyloid cascade hypoth-
esis of AD pathogenesis (Hardy & Selkoe, 2002), making
this model particularly suitable for the validation of this
hypothesis.
In conclusion, the development of mouse models of
tauopathies has brought research closer to an accurate repli-
cation of neurodegenerative processes in AD, and this ulti-
mately should help elucidate the causes of neuronal death
and cognitive decline in this type of dementia. Understanding
the interplay between genetic, epigenetic, and environmental
risk factors underlying dementia is a conditio sine qua non
for the development of preventive and curative therapies. In
this respect, the present mouse models have proved to be
robust and have already contributed to our understanding of
basic biology and pathogenesis of AD. One major problem
when investigating mouse models of AD is how well the
complex cognitive characteristics of human patients can be
replicated in mice and what would be the most sensitive tests
to assess cognitive deficits in mice that resemble the cogni-
tive deficits in human patients.
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Perspectives and Future Directions
for the Study of Cognition in Rodents
A genetic influence on cognitive abilities in health and dis-
ease in mice and man is well supported by the literature as
outlined above. However, increased knowledge about genetic
mechanisms and expression throughout development has
brought with it appreciations of the complexity of those gene
effects on behavior. The old presumptions of a few key genes
influencing one behavior regardless of background factors
are long obsolete. We are now also aware how difficult it is
to select behavioral tasks and interpret behavioral data when
studying a gene–behavior relationship. The wealth of avail-
able data and the multitude of techniques on hand to investi-
gate gene effects on cognition should provide ample material
for more refined future research, if only the appropriate care
and attention are taken. Progress is likely to appear along all
three lines of research discussed here.
Continuing efforts in psychometric research will hope-
fully provide a better understanding as to what extent
behavioral tasks and their multiple parameters inform on
general cognitive, specific cognitive, or confounding traits.
The results should provide us with improved behavioral
test batteries which reliably profile both cognitive and non-
cognitive processes so that genetic effects or other manip-
ulations can be correctly categorized and quantified. These
test batteries will not necessarily be more extensive; but
they will include only those tasks and their parameters with
known high loadings for specific behavioral aspects. Thus
the psychometric research is also providing the critical ser-
vice of selecting and refining individual tasks with a view to
maximizing key information. Improved behavioral test bat-
teries will certainly be the basis of the quantitative genetic
approach as well as proving necessary to other approaches
looking for accurate explanations of the relationship between
their gene of interest and cognition.
A quantitative genetic approach to cognition in mice
will benefit from better cognitive test batteries as well
as new resources and techniques. Whole genome single
nucleotide polymorphism (SNP) panels for mice are avail-
able which potentially allow a more comprehensive search
for quantitative trait loci associated with cognitive abili-
ties and other behavioral traits (Moran et al., 2006; Petkov
et al., 2004; Tsang et al., 2005; Yan, Wang, Lemon, &
You, 2004). These SNP panels very likely will be expanded
in the future. In addition to more mouse SNPs, pooled
DNA analysis and microarrays could potentially reduce
costs in the future; these techniques have been intro-
duced in human research to detect phenotype-specific quan-
titative trait loci (for review, see Butcher, Kennedy, &
Plomin, 2006). Finally, RNA microarrays can help to indicate
genes whose expression level correlates with performance
level in learning and memory paradigms (see, e.g., Caval-
laro, D’Agata, Manickam, & Alkon, 2002; D’Agata & Cav-
allaro, 2003; Leil, Ossadtchi, Cortes, Leahy, & Smith, 2002;
Leil, Ossadtchi, Nichols, Leahy, & Smith, 2003; Letwin
et al., 2006; Paratore et al., 2006; Robles et al., 2003), thus
really examining the gene contributions in a quantitative
way.
A molecular genetic approach to finding genes for cogni-
tive abilities, or more specifically for learning and memory,
will profit from a number of recent technical developments.
Genetically engineered mice have been developed in which
gene expression can be switched on and off at any time dur-
ing development (Michalon, Koshibu, Baumgartel, Spirig,
& Mansuy, 2005; Uchida et al., 2006). This technique has
already been used to investigate, for example, the role of cal-
cineurin in learning and memory (Genoux et al., 2002). Gene
delivery to specific brain areas can be achieved through injec-
tion of a compound consisting of a viral vector and specific
gene in mice as well as other species. Such viral transfection
has been successfully applied to deliver human apolipopro-
tein E isoforms into the brains of mice modeling AD (Dodart
et al., 2005). The application of gene transfer to limbic sys-
tem research has been discussed and reviewed by Robert
Sapolsky (2003). Another more recent approach that might
help to elucidate the role of genes in learning and memory
is gene silencing by small interfering RNAs injected into the
brain (for review, see McManus & Sharp, 2002; Novina &
Sharp, 2004).
In the field of genetically determined or predisposed cog-
nitive disabilities, clinical research and investigation of ani-
mal models will continue to influence each other. Clinical
studies can detect further genes causing or promoting differ-
ent forms of cognitive impairments. Modeling gene defects
in mice can help to understand the role gene products play
in synaptic or cellular processes. Mouse models may also
help to test potential therapeutic approaches. This field is
rapidly moving and it is impossible to provide an exhaus-
tive account of this research area. For readers who are inter-
ested in learning more, we would like to mention several
key papers (Austin et al., 2003; Dodart et al., 2002a; Janus
et al., 2000b; Kotilinek et al., 2002; Sigurdsson, Scholt-
zova, Mehta, Frangione, & Wisniewski, 2001) and reviews
(Bush, 2001; Dodart et al., 2002b; Duff, 1999; Janus, 2003)
that chronicle the history of immunization against Aβ in
mouse models, and the subsequent results of clinical trials
(Gilman et al., 2005; Hock et al., 2002, 2003; Orgogozo
et al., 2003).
In summary, the study of cognitive processes and cogni-
tive abilities in rodents does not suffer from lack of useful-
ness to the understanding of human brain function and dis-
ease; nor is there a lack of genetic or neuroscience technol-
ogy to back it up; nor is there a lack of scientists trying to
find genes associated with cognition. What is sorely lacking,
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however, is the behavioral technology to give clear interpre-
tations of the genetic manipulation effects. Huge numbers of
genes have been ‘characterized’ in terms of ‘cognitive’ tasks,
but the interpretation in most of these results is dubious by
virtue of very limited behavior information interpreted with
simplistic or wishful thinking. The field of rodent psycho-
metrics, which initially faded somewhere in the 1960s before
it was really born, has recently surged back into the spotlight.
Simply put; with all the bucketful of candidate genes pouring
into different tests, we need to know the structure of rodent
cognition and we need to know what our tasks really mea-
sure. It is already observed that as no one task measuresAQ8
one thing purely, combinations (‘batteries’) of tasks are the
only way to fully profile the difference between a wild type
and a manipulated group. Psychometrics in animals, as with
humans, offers the best data-driven way to clean up and col-
late our cognitive tasks into the informative batteries that we
should have had a long time ago.
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Chapter 11
Query No. Page No. Line No. Query
AQ1 161 02 The word ‘submitted’ has been changed to ‘subjected’ in this sentence and hence forth. Please check.
AQ2 161 20 Please check the sense of the sentence ‘Variability in processes involved in neural development and plas-
ticity plausible candidates influencing ‘g”.
AQ3 162 21 Please advise whether “Genetically engineering mice is” can be changed to “Genetically engineered mice
are” in the sentence “Genetically engineering mice is only one way to investigate. . .”
AQ4 165 15 “FMR1” has been changed to “Fmr1” in the sentence “Fragile X syndrome in humans is due. . .”. Please
check.
AQ5 167 19 Please advise whether “temporal and spatial expression pattern” can be changed to “temporal and spatial
expression patterns” in the sentence “Most of the mouse models which replicate. . .”
AQ6 167 06 Please check whether the edit of “Behavioral studies from different laboratories...” is ok.
AQ7 167 26 Please advise whether “regional and temporal pattern” can be changed to “regional and temporal patterns”
in the sentence “The regional and temporal pattern[0] of pathology. . .”
AQ8 168 12 “on” has been changed to “one” in the sentence “It is already observed that. . .”. Please check whether this
is correct.
AQ9 173 05 Please update.
